We provide you with 20 years of free, institutional-grade data for LYRA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LYRA. Explore the full financial landscape of LYRA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Lyra Therapeutics, Inc(NASDAQ:LYRA) 
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's XTreo technology platform is designed to deliver...
Website: http://www.lyratherapeutics.com
Founded: 2005
Full Time Employees: 33
CEO: Maria Palasis
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about LYRA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.